Pullen Investment Management LLC Makes New Investment in Humana Inc. $HUM

Pullen Investment Management LLC acquired a new stake in Humana Inc. (NYSE:HUM) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,009 shares of the insurance provider’s stock, valued at approximately $348,000.

Other hedge funds also recently made changes to their positions in the company. Hsbc Holdings PLC grew its holdings in Humana by 9.1% during the 4th quarter. Hsbc Holdings PLC now owns 330,794 shares of the insurance provider’s stock valued at $85,107,000 after purchasing an additional 27,530 shares in the last quarter. Reflection Asset Management acquired a new position in Humana in the 4th quarter worth $29,000. Invesco Ltd. lifted its holdings in Humana by 9.3% in the 4th quarter. Invesco Ltd. now owns 2,233,130 shares of the insurance provider’s stock worth $571,972,000 after buying an additional 189,670 shares in the last quarter. Corient Private Wealth LLC boosted its position in Humana by 329.3% in the 4th quarter. Corient Private Wealth LLC now owns 120,104 shares of the insurance provider’s stock valued at $30,762,000 after buying an additional 92,125 shares during the last quarter. Finally, Ameriflex Group Inc. purchased a new position in Humana in the 4th quarter valued at about $128,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of Humana stock opened at $360.84 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $380.86. The firm’s 50-day simple moving average is $285.88 and its 200-day simple moving average is $241.60. The firm has a market cap of $43.32 billion, a PE ratio of 38.59, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same period last year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts forecast that Humana Inc. will post 9.04 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.0%. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Zacks Research raised Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Bank of America raised their price objective on Humana from $267.00 to $340.00 and gave the company a “neutral” rating in a research note on Thursday, June 4th. Mizuho lifted their price objective on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, Weiss Ratings raised Humana from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, June 12th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $291.35.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.